TITLE

COMMENTARY: Adults who require inhaled corticosteroids benefits from a moderate starting dose

AUTHOR(S)
Thien, Frank
PUB. DATE
November 2004
SOURCE
ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p72
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
iThe article presents a commentary on the study, which concluded that adults who require inhaled corticosteroids benefits from a moderate starting dose. Airway inflammation is the key pathologic feature of asthma, and ICSs remain the most effective anti-inflammatory medication and the cornerstone of asthma pharmacotherapy. However, some other features of asthma, such as airway smooth muscle dysfunction (manifesting as AHR), respond more slowly, and airway remodeling does not seem to respond to ICS at all.
ACCESSION #
15303595

 

Related Articles

  • Treatment Comparison of Budesonide/ Formoterol with Salmeterol/Fluticasone Propionate in Adults Aged ≥16 Years with Asthma: Post Hoc Analysis of a Randomized, Double-Blind Study. Kuna, Piotr // Clinical Drug Investigation;2010, Vol. 30 Issue 9, p565 

    Background: Three fixed maintenance-dose inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) combinations for the treatment of asthma are currently available: salmeterol/fluticasone propionate (Seretide™/Advair™/ Adoair™) budesonide/formoterol (Symbicort®) and...

  • Biopharmaceutical Therapeutics for Asthma Remodeling. Das, A. M.; Griswold, D. E.; Torphy, T. J.; Li, L. // Current Pharmaceutical Design;Sep2006, Vol. 12 Issue 25, p3233 

    Current asthma therapy is aimed at controlling disease symptoms. A subset of asthma patients remains symptomatic despite optimal therapy indicating that an unmet medical need exists for these patients. Innovative therapeutics are needed to treat the unmet need in asthma and biopharmaceutical...

  • Mild persistent asthma and inhaled corticosteroids: is daily therapy really necessary? Bauchner, Howard // Archives of Disease in Childhood;Oct2005, Vol. 90 Issue 10, p1094 

    This article cites a study on the treatment of mild persistent asthma, which was published in the May 6, 2005 issue of the "Journal Watch Pediatrics and Adolescent Medicine." In this double-blind trial, researchers randomized 225 adults with mild persistent asthma to receive twice-daily inhaled...

  • Magnesium and Outcomes in Children with Acute Asthma. Sadovsky, Richard // American Family Physician;6/15/2001, Vol. 63 Issue 12, p2441 

    Presents information on a study by R.J. Scarfone and others that studied the early administration of magnesium to moderately to severely ill children with asthma in a randomized, double-blind, placebo-controlled clinical trial. Description of the study and its results; Conclusion that among a...

  • Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. Partridge, Martyn R.; van der Molen, Thys; Myrseth, Sven-Erik; Busse, William W. // BMC Pulmonary Medicine;2006, Vol. 6, p13 

    Background: This study examined the attitudes and actions of 3415 physician-recruited adults aged ⩾ 16 years with asthma in eleven countries who were prescribed regular maintenance therapy with inhaled corticosteroids or inhaled corticosteroids plus long-acting β2-agonists. Methods:...

  • Review: Inhaled corticosteroids slow the progression of airflow limitation in COPD: COMMENTARY. Greenstone, Michael // ACP Journal Club;May/Jun2004, Vol. 140 Issue 3, p57 

    Chronic obstructive pulmonary disease (COPD) is largely a disease of vulnerable smokers in whom the normal age-related decline in lung function is accelerated from a mean of 30 mL/y to 60 mL/y. Unlike asthma, the airflow obstruction and airway inflammation of COPD respond poorly to...

  • When to use and when not to use inhaled corticosteroids in COPD. Antón, Esther; Miravitlles, Marc // Hot Topics in Respiratory Medicine;2013, Issue 24, p13 

    The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease (COPD) management is still controversial. There is widespread use of ICS in COPD patients probably because this disease is characterized by airway inflammation, as well as the evident therapeutic benefits of ICS...

  • Bronchial Asthma -- Patient Expectations and the Role in Asthma Care. Scott, P. // West Indian Medical Journal;Jun2009, Vol. 58 Issue 3, p193 

    The author reflects on the progress in treatment bronchial asthma. The author says that the focus on asthma care has transformed from solely focusing on symptom relief to a result-driven philosophy. The author notes that the use of inhaled corticosteroids has remained significantly below the...

  • Management of asthma in children. Townshend, J.; Hails, S.; Mckean, M. // BMJ: British Medical Journal (International Edition);8/4/2007, Vol. 335 Issue 7613, p253 

    The article presents an overview of the management of asthma in children. A discussion of what the acute managemnt of asthma, long term management of atopic asthma and episodic viral wheeze is is presented. The benefits and disadvantages of the use of corticosteroids and long acting beta...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics